C612-1373 Screening compound: N-(3-methoxyphenyl)-2-(4-{[(4-methoxyphenyl)methyl]carbamoyl}piperidin-1-yl)pyridine-4-carboxamide

C612-1373 Screening compound: N-(3-methoxyphenyl)-2-(4-{[(4-methoxyphenyl)methyl]carbamoyl}piperidin-1-yl)pyridine-4-carboxamide
C612-1373 Screening compound: N-(3-methoxyphenyl)-2-(4-{[(4-methoxyphenyl)methyl]carbamoyl}piperidin-1-yl)pyridine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C612-1373
N-(3-methoxyphenyl)-2-(4-{[(4-methoxyphenyl)methyl]carbamoyl}piperidin-1-yl)pyridine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C612-1373

Molecular Formula

C27H30N4O4 (C27 H30 N4 O4)

Compound Name

N-(3-methoxyphenyl)-2-(4-{[(4-methoxyphenyl)methyl]carbamoyl}piperidin-1-yl)pyridine-4-carboxamide

IUPAC name

N-(3-methoxyphenyl)-2-(4-{[(4-methoxyphenyl)methyl]carbamoyl}piperidin-1-yl)pyridine-4-carboxamide

SMILES

COc1ccc(CNC(C(CC2)CCN2c2nccc(C(Nc3cc(OC)ccc3)=O)c2)=O)cc1

InChI

InChI=1S/C27H30N4O4/c1-34-23-8-6-19(7-9-23)18-29-26(32)20-11-14-31(15-12-20)25-16-21(10-13-28-25)27(33)30-22-4-3-5-24(17-22)35-2/h3-10,13,16-17,20H,11-12,14-15,18H2,1-2H3,(H,29,32)(H,30,33)

InChI Key

PSLQXRUJBXVXCW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14776010

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

474.56

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.786

Distribution Coefficient, logD

3.786

Water Solubility, LogSw

-3.95

Polar Surface Area

74.794

Acid Dissociation Constant (pKa)

11.03

Base Dissociation Constant (pKb)

8.45

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.60

C612-1373 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

CNS Targets (44014 compounds)

CNS targets activity set (6557 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Targeted Diversity Library (40567 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Proteases

References: we are preparing a list of scientific research reports with C612-1373 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C612-1373?
Check Price and Availability of C612-1373, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C612-1373 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C612-1373
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C612-1373
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C612-1373 available by request